Publications in collaboration with researchers from University of Milan (4)

2023

  1. Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial

    The Lancet, Vol. 401, Núm. 10371, pp. 105-117

2021

  1. Pembrolizumab plus eribulin in hormone-receptor–positive, HER2-negative, locally recurrent or metastatic breast cancer (KELLY): An open-label, multicentre, single-arm, phase Ⅱ trial

    European Journal of Cancer, Vol. 148, pp. 382-394

  2. Relationships Between Köhne Category/Baseline Tumor Load and Early Tumor Shrinkage, Depth of Response, and Outcomes in Metastatic Colorectal Cancer

    Clinical Colorectal Cancer, Vol. 20, Núm. 4, pp. 305-313

2013

  1. Class II Phosphoinositide 3-Kinases Contribute to Endothelial Cells Morphogenesis

    PLoS ONE, Vol. 8, Núm. 1